Nice Insight is unique in enabling you to compare a large number of
CROs based on impartial reviews from thousands of respected peers that
buy outsourced services, rather than relying on the typical claims that
make them all appear the same. Learn who is rated highest for the leading
drivers: quality, reliability, regulatory, affordability, productivity and innovation –
and quickly establish a shortlist that best aligns with your strategy.
Search. Compare. Contact.
Sample Nice Insight with open access to limited top line data on
our website – optimized for smart phones, tablets and desktops
For more information, contact Nigel Walker, Managing Director
at nigel@thatsnice.com or +1 212 366 4455.
www.niceinsight.com
Compare impartial peer reviews to fi nd your ideal CRO
louis pasteur
New indication identifi ed
through extended study
CRO unable to handle
increased study demands
Public biotech demands
robust protocol
Transactional PK pricing
drives down price
Company No. 1 Company No. 2 Company No. 3 Company No. 4 Company No.
5
Technology investment oΩ ers
increased sensitivity
Capital exposure costs have to
be absorbed / passed
galileo galilei marie curie ignaz semmelweis robert koch
New clinical trial awarded to
established CRO
Start date delayed due to
recruitment challenge
Preclinical primate study
awarded to US domestic CRO
Candidate stress identifi ed in
transported colony
NIXX_LSL0614.indd 1 5/13/14 10:19 AM